Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Stretching the limbs? Tonic spasms in multiple sclerosis.
No evidence for a role of rare CYP27B1 functional variations in multiple sclerosis.
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
Expanded CD8 T-cell sharing between periphery and CNS in multiple sclerosis.
An Overview of Models, Methods, and Reagents Developed for Translational Autoimmunity Research in the Common Marmoset (Callithrix jacchus).
Natalizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy - A Report of Three Cases.
Association between alcohol consumption and multiple sclerosis: a meta-analysis of observational studies.
MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients.
Do Not Miss the Eye in Acute Demyelinating Encephalomyelitis.
Corpus Callosum Atrophy Correlates with Gray Matter Atrophy in Patients with Multiple Sclerosis.
Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication.
Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis.
Electrophysiological patterns of oropharyngeal swallowing in multiple sclerosis.
Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
A new model for primary-progressive multiple sclerosis?
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.
Polyomavirus JC infection inhibits differentiation of oligodendrocyte progenitor cells.
G protein-coupled receptors as therapeutic targets for multiple sclerosis.
Requirement for interleukin-1 to drive brain inflammation reveals tissue-specific mechanisms of innate immunity.
Erratum to: Genomic Binding Sites and Biological Effects of the Vitamin D-VDR Complex in Multiple Sclerosis.
PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease.
Characterization of the first K(+) channel blockers from the venom of the Moroccan scorpion Buthus occitanus Paris.
Opexa Therapeutics provides MS trial enrollment update; 70% of patients enrolled

Pages